PTGS2 and congestive heart failure: Selective cyclooxygenase-2 (COX-2) inhibitors reduce the incidence of upper gastrointestinal tract ulcerations; however, their side effects include fluid retention, hypertension, congestive heart failure, renal insufficiency and a risk of cardiovascular thrombosis.4